Archives melanoma

by in
Entry Author Date Location
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer 01/19/11 San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Plexxikon Opts to Co-Promote with Genentech 01/06/11 San Francisco
Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons 01/04/11 San Francisco
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics 10/08/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
iPierian Entices Corporate VCs, Plexxikon’s One-Two Punch, Jennerex’s Road Less Traveled, & More Bay Area Life Sciences News 09/10/10 San Francisco
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled 09/09/10 San Francisco
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer 09/07/10 San Francisco
A Bidding War for 3Par, a Trademark War over Mafia Wars, a Barrage of New Y Combinator Startups, & More Bay Area BizTech and Life Sciences News 08/30/10 San Francisco
Promising Skin Cancer Drug Could Be First Big Win for Plexxikon’s Structure-Based Drug Discovery Approach 08/26/10 San Francisco
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug 07/12/10 Boston
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Bezos Family Pledges $10M to the “Hutch” for Next-Generation Cancer Therapies 11/23/09 Seattle
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus 11/10/09 Boston
Zymo Melanoma Drug Shrinks Tumors 05/13/09 Seattle
Synta Melanoma Drug Fails Disastrously in Clinical Trial, As Patients Show Higher Death Rate 02/26/09 Boston
Synta Melanoma Data Coming in May 02/02/09 Boston
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial 01/27/09 Boston
Synta Gets $25M From Glaxo For Cancer Drug Milestone 10/14/08 Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial 06/01/08 Boston
Page 2 of 2 « previous page